The DOI matches its Crossref record; 265 of the 265 references it cites were found in a registry or an index.
Recent insights on the role of cholesterol in non-alcoholic fatty liver disease
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–265 of 265
Nonalcoholic Fatty Liver Disease and the Metabolic Syndrome: Clinical Implications and Treatment
Rahimi, R. S., & Landaverde, C. E. (2013) · Nutrition in Clinical Practice · doi:10.1177/0884533612470464 · Cited by 69
Marí, M., Morales, A., Colell, A., García‐Ruiz, C., & Fernández-Checa, J. C. (2014) · Redox Biology · doi:10.1016/j.redox.2014.09.005 · Cited by 68
Mechanisms of Biliary Lipid Secretion and Their Role in Lipid Homeostasis
Elferink, R. P. J. O., & Groen, A. K. (2000) · Seminars in Liver Disease · doi:10.1055/s-2000-9385 · Cited by 67
Okada, Y., Yamaguchi, K., Nakajima, T., Nishikawa, T., Jo, M., Mitsumoto, Y., Kimura, H., Nishimura, T., Tochiki, N., Yasui, K., et al. (2012) · Liver International · doi:10.1111/liv.12033 · Cited by 66
Fuchs, M. A., Lammert, F., Wang, D. Q. ‐., Paigen, B. J., Carey, M. C., & Cohen, D. E. (1998) · Biochemical Journal · doi:10.1042/bj3360033 · Cited by 65
Zhou, T., Li, S., Zhong, W., Vihervaara, T., Béaslas, O., Perttilä, J., Luo, W. F., Jiang, Y., Lehto, M. J., Olkkonen, V. M., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0021078 · Cited by 64
Su, K., Sabeva, N. S., Liu, J., Wang, Y., Bhatnagar, S., van der Westhuyzen, D. R., & Graf, G. A. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.360081 · Cited by 63
Cholesterol and nonalcoholic fatty liver disease: Renewed focus on an old villain
Kerr, T. A., Davidson, N. O., Groszmann, R. J., Iwakiri, Y., & Taddei, T. H. (2012) · Hepatology · doi:10.1002/hep.26088 · Cited by 63
Lavigne, P., Najmanivich, R., & Lehoux, J. (2010) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/978-90-481-8622-8_15 · Cited by 62
Convergent pathways that cause hepatic fibrosis in NASH
Friedman, S. L. (2013) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2012.256 · Cited by 58
Robiou-du-Pont, S., Bonnefond, A., Yengo, L., Vaillant, E., Lobbens, S., Durand, E., Weill, J., Lantieri, O., Balkau, B., Charpentier, G., et al. (2012) · International Journal of Obesity · doi:10.1038/ijo.2012.175 · Cited by 57
Suppression of ABCA1 by unsaturated fatty acids leads to lipid accumulation in HepG2 cells
Yang, Y., Jiang, Y., Wang, Y.-T., & An, W. (2010) · Biochimie · doi:10.1016/j.biochi.2010.04.002 · Cited by 57
Fuchs, M. A., Ivandic, B., Müller, O. J., Schalla, C., Scheibner, J., Bartsch, P., & Stange, E. F. (2001) · Hepatology · doi:10.1053/jhep.2001.24373 · Cited by 56
The role of signalling in cellular cholesterol homeostasis
Luu, W., Sharpe, L. J., Gelissen, I. C., & Brown, A. J. (2013) · IUBMB Life · doi:10.1002/iub.1182 · Cited by 55
Arrese, M., & Karpen, S. J. (2010) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2010.2 · Cited by 54
Self-citationCampbell, A. M., & Chan, S. H. P. (2008) · Journal of Bioenergetics and Biomembranes · doi:10.1007/s10863-008-9138-x · Cited by 54
Cholesterol-lowering therapy for the treatment of nonalcoholic fatty liver disease: an update
Musso, G., Cassader, M., & Gambino, R. (2011) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e32834c37ee · Cited by 53
Zhao, B., Song, J., & Ghosh, S. (2008) · Journal of Lipid Research · doi:10.1194/jlr.m800277-jlr200 · Cited by 53
Bhathena, J., Martoni, C., Kulamarva, A. G., Tomaro-Duchesneau, C., Malhotra, M., Paul, A., Urbanska, A. M., & Prakash, S. (2013) · PLoS ONE · doi:10.1371/journal.pone.0058394 · Cited by 52
Corey, K. E., & Chalasani, N. (2013) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2013.08.014 · Cited by 51
Jelinek, D. F., Millward, V., Birdi, A., Trouard, T. P., Heidenreich, R. A., & Garver, W. S. (2010) · Human Molecular Genetics · doi:10.1093/hmg/ddq466 · Cited by 51
de Bari, O., Neuschwander‐Tetri, B. A., Liu, M., Portincasa, P., & Wang, D. Q. ‐. (2011) · Journal of Lipids · doi:10.1155/2012/302847 · Cited by 50
Turley, S. D., Daggy, B. P., & Dietschy, J. M. (1996) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-199601000-00012 · Cited by 48
Recent insights into farnesoid X receptor in non-alcoholic fatty liver disease
Xu, J., Li, Z.-P., Zhang, L., & Ji, G. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i37.13493 · Cited by 48
Upregulation of caveolin-1 and SR-B1 in mice with non-alcoholic fatty liver disease
Qiu, Y., Liu, S., Chen, H., Yu, C., Teng, X., Yao, H., & Xu, G. (2013) · Hepatobiliary & pancreatic diseases international · doi:10.1016/s1499-3872(13)60099-5 · Cited by 48
The voltage dependent anion channel affects mitochondrial cholesterol distribution and function
Campbell, A. M., & Chan, S. H. P. (2007) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2007.06.012 · Cited by 47
Joe Goldstein and Mike Brown: from cholesterol homeostasis to new paradigms in membrane biology.
Anderson, R. G. W. (2003) · Trends in Cell Biology · doi:10.1016/j.tcb.2003.08.007 · Cited by 47
Rapid Development of Non-Alcoholic Steatohepatitis in Psammomys obesus (Israeli Sand Rat)
Spolding, B., Connor, T., Wittmer, C., de Abreu, L. L. F., Kaspi, A., Ziemann, M., Kaur, G., Cooper, A., Morrison, S., Lee, S., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0092656 · Cited by 46
Mechanisms of Liver Injury in Non-Alcoholic Steatohepatitis
Duwaerts, C. C., & Maher, J. J. (2014) · Current Hepatology Reports · doi:10.1007/s11901-014-0224-8 · Cited by 46
Enjoji, M., & Nakamuta, M. (2010) · World Journal of Gastroenterology · doi:10.3748/wjg.v16.i7.800 · Cited by 45
Wang, D. Q. ‐., Portincasa, P., & Neuschwander‐Tetri, B. A. (2013) · Comprehensive physiology · doi:10.1002/cphy.c130001 · Cited by 44
Ezetimibe Therapy for Dyslipidemia: An Update
Katsiki, N., Theocharidou, E., Karagiannis, A. I., Athyros, V. G., & Mikhailidis, D. P. (2013) · Current Pharmaceutical Design · doi:10.2174/13816128113199990314 · Cited by 44
Activated hepatic stellate cells in liver cirrhosis. A morphologic and morphometrical study.
Carpino, G., Franchitto, A., Morini, S., Corradini, S. G., Merli, M., & Gaudio, E. (2004) · PubMed · Cited by 42
Statins in Nonalcoholic Fatty Liver Disease and Steatohepatitis: Updated Review
Nseir, W., & Mahamid, M. (2013) · Current Atherosclerosis Reports · doi:10.1007/s11883-012-0305-5 · Cited by 41
Nonalcoholic fatty liver disease and cholesterol gallstones: Which comes first?
Ahmed, M. H., & Ali, A. (2014) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365521.2014.894119 · Cited by 41
Decreased Npc1 Gene Dosage in Mice Is Associated With Weight Gain
Jelínek, D., Heidenreich, R. A., Erickson, R. P., & Garver, W. S. (2009) · Obesity · doi:10.1038/oby.2009.415 · Cited by 39
Adipocyte Cell Death, Fatty Liver Disease and Associated Metabolic Disorders
Eguchi, A., & Feldstein, A. E. (2014) · Digestive Diseases · doi:10.1159/000360509 · Cited by 39
de Keyser, C. E., Koehler, E. M., Schouten, J. N. L., Visser, L. E., Albert Hofman, D., Janssen, H. L. A., & Stricker, B. H. C. (2014) · Digestive and Liver Disease · doi:10.1016/j.dld.2014.04.002 · Cited by 38
Metabolomic signatures in lipid‐loaded HepaRGs reveal pathways involved in steatotic progression
Brown, M. V., Compton, S. A., Milburn, M. V., Lawton, K. A., & Cheatham, B. (2013) · Obesity · doi:10.1002/oby.20440 · Cited by 37
Altered distribution of caveolin‐1 in early liver steatosis
Mastrodonato, M., Calamita, G., Rossi, R., Mentino, D., Bonfrate, L., Portincasa, P., Ferri, D., & Liquori, G. E. (2011) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2010.02459.x · Cited by 34
Calderón‐Domínguez, M., Gil, G., Medina, M. Á., Pandak, W. M., & Rodríguez‐Agudo, D. (2014) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2014.01.002 · Cited by 34
OSBP-Related Proteins: Liganding by Glycerophospholipids Opens New Insight into Their Function
Olkkonen, V. M. (2013) · Molecules · doi:10.3390/molecules181113666 · Cited by 34
A Perspective on Metabolic Syndrome and Nonalcoholic Fatty Liver Disease
Targher, G., & Byrne, C. D. (2015) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2015.1502 · Cited by 33
ApoA-I or ABCA1 expression suppresses fatty acid synthesis by reducing 27-hydroxycholesterol levels
Ma, D., Liu, W., & Wang, Y.-T. (2014) · Biochimie · doi:10.1016/j.biochi.2014.04.010 · Cited by 32
Pathophysiology guided treatment of nonalcoholic steatohepatitis
Nguyen, T. A. T., & Sanyal, A. J. (2012) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2011.07018.x · Cited by 30
Hepatic Steatosis and Steatohepatitis: Are they Really Two Distinct Entities?
Fielding, C. M., & Angulo, P. (2014) · Current Hepatology Reports · doi:10.1007/s11901-014-0227-5 · Cited by 28
Su, K., Sabeva, N. S., Wang, Y., Liu, X., Lester, J. D., Liu, J., Liang, S., & Graf, G. A. (2013) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.113.302355 · Cited by 26
Arrese, M. A. (2008) · Hepatology · doi:10.1002/hep.22783 · Cited by 26
Self-citationRegulation of bile acid homeostasis by the intestinal Diet1–FGF15/19 axis
Reue, K., Lee, J. M., & Vergnes, L. (2014) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000060 · Cited by 26
The effect of ezetimibe on NAFLD
Averna, M. R. (2015) · Atherosclerosis Supplements · doi:10.1016/s1567-5688(15)50007-x · Cited by 24
Munechika, Enjoji, Makoto, M., & Nakamuta (2010) · Acta Scientiarum Naturalium Universitatis Sunyatseni · Cited by 24
Soffientini, U., Caridis, A.-M., Dolan, S., & Graham, A. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2014.07.002 · Cited by 22
Overexpression of the cholesterol-binding protein MLN64 induces liver damage in the mouse
Tichauer, J. E., Morales, M. G., Amigo, L., Galdames, L., Klein, A. D., Quiñones, V., Ferrada, C., Alvarez, A. R., Rio, M., Miquel, J. F., et al. (2007) · World Journal of Gastroenterology · doi:10.3748/wjg.v13.i22.3071 · Cited by 22
Self-citationThe unique case of the Niemann-Pick type C cholesterol storage disorder.
Klein, A. D., Alvarez, A. R., & Zanlungo, S. (2014) · PubMed · Cited by 21
Self-citationLipid-lowering agents in the management of nonalcoholic fatty liver disease
Τζιόμαλος, Κ. (2014) · World Journal of Hepatology · doi:10.4254/wjh.v6.i10.738 · Cited by 21
Lipoprotein Metabolism and Cholesterol Balance
Cohen, D. E. (2009) · Wiley eBooks · doi:10.1002/9780470747919.ch19 · Cited by 17
Determinants of transhepatic cholesterol flux and their relevance for gallstone formation
Zanlungo, S., & Rigotti, A. (2009) · Liver International · doi:10.1111/j.1478-3231.2009.01972.x · Cited by 17
Self-citationEmerging role of cellular cholesterol in the pathogenesis of nonalcoholic fatty liver disease
Bashiri, A., Tavallaee, G., Li, L., & Ng, D. S. (2013) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e328361633e · Cited by 16
Ezetimibe in the balance: can cholesterol-lowering drugs alone be an effective therapy for NAFLD?
Musso, G. (2014) · Diabetologia · doi:10.1007/s00125-014-3192-1 · Cited by 14
Excess cholesterol and fat in the diet: A dangerous liaison for energy expenditure and the liver
Neuschwander‐Tetri, B. A., & Wang, D. Q. ‐. (2012) · Hepatology · doi:10.1002/hep.25953 · Cited by 13
Quantitative Proteomic Survey of Endoplasmic Reticulum in Mouse Liver
Song, Y., Jiang, Y., Ying, W., Gong, Y. Q., Yan, Y., Yang, D. S., Ma, J., Xue, X., Zhong, F., Wu, S., et al. (2010) · Journal of Proteome Research · doi:10.1021/pr900146t · Cited by 13
Ono, M., & Saibara, T. (2012) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2012.07084.x · Cited by 12
Tagawa, H., Irie, J., Itoh, A., Kusumoto, Y., Kato, M., Kobayashi, N., Tanaka, K., Morinaga, R., Fujita, M., Nakajima, Y., et al. (2015) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2015.04.025 · Cited by 12
Obeticholic acid: expanding the therapeutic landscape of NASH
Arrese, M. A., Cabrera, D., & Francisco Barrera, M. (2015) · Annals of Hepatology · doi:10.1016/s1665-2681(19)31286-4 · Cited by 9
Self-citationEffects of bile acid sequestration on hepatic steatosis in obese mice
Solís, N., Pizarro, M., Quintero, P., Arab, J. P., Riquelme, A. J., Padilla, O., Carrasco-Aviño, G., Pirola, C. J., Sookoian, S., & Arrese, M. A. (2014) · Annals of Hepatology · doi:10.1016/s1665-2681(19)30911-1 · Cited by 7
Self-citation
Cited by
Fenton, S. E., Ducatman, A., Boobis, A., DeWitt, J. C., Lau, C., Ng, C., Smith, J. S., & Roberts, S. M. (2020) · Environmental Toxicology and Chemistry · doi:10.1002/etc.4890 · Cited by 2,445
Triggering and resolution of inflammation in NASH
Schuster, S., Cabrera, D., Arrese, M., & Feldstein, A. E. (2018) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-018-0009-6 · Cited by 943
Self-citationRecent insights into the pathogenesis of nonalcoholic fatty liver disease
Arab, J. P., Arrese, M., & Trauner, M. (2018) · Annual Review of Pathology Mechanisms of Disease · doi:10.1146/annurev-pathol-020117-043617 · Cited by 573
Self-citationMolecular mechanisms of lipotoxicity and glucotoxicity in nonalcoholic fatty liver disease
Mota, M., Banini, B. A., Cazanave, S. C., & Sanyal, A. J. (2016) · Metabolism · doi:10.1016/j.metabol.2016.02.014 · Cited by 570
The Role of Cholesterol in the Pathogenesis of NASH
Ioannou, G. N. (2016) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2015.11.008 · Cited by 498
Metadata
- Authors
- Arguello, G., Balboa, E., Arrese, M., & Zanlungo, S.
- Venue
- Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
- Publisher
- Elsevier BV
- Published
- 2015-09
- Volume
- 1852
- Issue
- 9
- Pages
- 1765-1778
- ISSN
- 0925-4439 (ISSN-L)
- OpenAlex
- W356196484
- Cited by
- 306
- References
- 265
- FWCI
- 17.20
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.